Foley Partner Courtenay Brinckerhoff authored an article titled “Court Ruling Could Lengthen Patent Term” in the February 1, 2010 issue of Genetic Engineering & Biotechnology News. Brinckerhoff discusses the Federal Circuit’s affirmation of Wyeth v. Kappos on the proper interpretation of the patent term adjustment (PTA) statute, stating that biotechnology patents may benefit from this ruling because of the timing and type of examination delays biotechnology applications often encounter. She adds that the decision provides additional opportunities to maximize patent term and enhance patent value by developing patent strategies that take the PTA provisions into account.
Author(s)
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.